期刊文献+

内皮抑素抑制喉鳞癌作用机制的初步探讨 被引量:1

The inhibitory mechanism of endostatin on laryngeal squamaous cell carcinoma
暂未订购
导出
摘要 目的探讨内皮抑素对喉鳞癌细胞(Hep-2)的作用及其可能的机制。方法①MTT法检测不同浓度(10—50μg/ml)的内皮抑素作用72h和30μg/ml的内皮抑素作用不同时间(24—72h)对Hep-2细胞的影响;②电镜观察Hep-2细胞超微结构的变化;③RT-PCR法检测Hep-2细胞内皮抑素作用组中Survivin基因的表达。结果①MTT检测显示,内皮抑素(20—50μg/ml)能抑制Hep-2细胞的增殖(P〈0.05,P〈0.01),具有剂量.时间依赖性;②电镜观察,Hep-2细胞内皮抑素作用组均出现凋亡改变;③RT-PCR结果,与正常Hep-2细胞对照组相比较药物作用组Survivin基因表达受到部分抑制,差异呈显著性(P〈0.01)。结论内皮抑素能抑制喉鳞癌Hep-2细胞,并具有时间-剂量依赖性,机制可能为诱导细胞凋亡。提示,内皮抑素可能通过诱导喉癌细胞本身的凋亡,对喉癌的生长与转移起到抑制作用。 Objective To evaluate the inhibitory effect and the possible mechanism of endostatin on laryngeal carcinoma cells (Hep-2). Methods ① By means of MTF assay, the influences of endostatin with different concentrations( 10 - 50μg/ml) and endostatin(30μg/ml) with different time(24 - 72h) on the livability of Hep- 2 cells were studied; ②The changes of Hep-2 cells' uhrastructures were examined by electron microscope; ③ After that, Survivin mRNA expression was measured in Hep-2 cells with endostatin(30μg/ml) by RT-PCR test. Results ①The growth of Hep-2 cells was significantly inhibited ( P 〈 0.05, P 〈 0.01 ) by endostatin (20 50μg/ml) ,what's more it presents dose-time-dependent; ②Apoptosis was observed in the groups of Hep-2 cells with endostatin by electron microscope;③The expression of Survivin in Hep-2 cells was partly inhibited by endostatin in the test of RT-PCR,and it was apparent difference compared with the cells without drugs( P 〈 0.01 ). Conclusion Endostatin can inhibit the proliferation of Hep-2 cells with time-dose-dependent and it's mechanism maybe induces the apoptosis. Prompt, Endostatin perhaps inhibit the growth and the transformation of laryngeal squamaous cells carcinoma through inducing the apoptosis of Hep-2 cells.
出处 《哈尔滨医科大学学报》 CAS 北大核心 2006年第4期282-285,共4页 Journal of Harbin Medical University
基金 黑龙江省自然科学基金资助项目(D0340)
关键词 内皮抑素 喉鳞癌细胞 凋亡 endostatin Hep-2 apoptosis
  • 相关文献

参考文献3

二级参考文献15

  • 1[1]Shi S,Sung BJ,Cho Y S,et al.An anti-apoptosic protein human survivin is a direct inhibitor of caspase-e and -7.Biochemistry,2001,40(4):1117-1123.
  • 2[2]Ambrosini G,Adida C,Altieri DC.A novel anti-apoptiosis gene,survivin,expressed in cancer and lymphoma.Nat Med,1997,3(8);917-921.
  • 3[3]Adida C,Crotty PL,Mograth J,et al.Developmentally regulated expression of the novel cancer anti-apoptosis gene survivn in human and mouse differentitaion.Am J Pathol,1998,152(1):43-49.
  • 4[4]Sharp JD,Hausladen DA,Maher MG,et al.Bladder cancer detection with urinary surviving,an inhibitor of apoptosis.Frontier in Bioscience,2002,1:36-42.
  • 5[5]Ambrosini G,Adida C,Sirugo G,et al.Induction of apoptosis and inhibition of cell proliferation by survivin gene targeting.J Biol Chem,1998,273(18):11177-11182.
  • 6Harris AL.Are angiostatin and endostatin cures for cancer? Lancet,1998,351:1598-1599.
  • 7O'Reilly MS,Boehm T,Shing Y,et al.Endostatin:an endogenous inhibitor of angiogenesis and tumor growth.Cell,1997,88:277-285.
  • 8Yokoyama Y,Green JE,Sukhatme VP,et al.Effect of endostatin on spontaneous tumorigenesis of mammary adenocarcinoma in a transgenic mouse model.Cancer Res,2000,60:4362-4365.
  • 9Boehm T,Folkman J,Browder T,et al.Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance.Nature,1997,390:404-407.
  • 10Dhanabal M,Ramchandran R,Volk R,et al.Endostatin:yeast production,mutants and antitumor effect in renal cell carcinoma.Cancer Res,1999,59:189-197.

共引文献35

同被引文献3

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部